Whitehawk Therapeutics, Inc. (WHWK)
(Delayed Data from NSDQ)
$2.42 USD
+0.01 (0.41%)
Updated Oct 27, 2025 04:00 PM ET
After-Market: $2.44 +0.02 (0.83%) 6:18 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WHWK 2.42 +0.01(0.41%)
Will WHWK be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for WHWK based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for WHWK
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
Implied Volatility Surging for Whitehawk Therapeutics Stock Options
WHWK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for WHWK
Is WHWK compressing before expansion? Calm After Storm shows up after declining 1.63%
Is WHWK ready to make a move? Calm After Storm shows up after gaining 3.38%
WHWK forms Upper Bollinger Band Walk on October 22
Is WHWK positioned for a breakout? Upper Bollinger Band Walk shows up after crashing 14.29%
WHWK forms Wide Range Bar on October 20